Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The impact of self-transcendence on physical health status promotion in multiple sclerosis patients attending peer support groups.
Mapping the 12-item multiple sclerosis walking scale to the EuroQol 5-dimension index measure in North American multiple sclerosis patients.
Role of Formyl Peptide Receptors (FPR) in Abnormal Inflammation Responses Involved in Neurodegenerative Diseases.
The ethics of placebo controlled clinical trials in NMO - A balance of risks.
First-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis.
When structure-affinity relationships meet structure-kinetics relationships: 3-((Inden-1-yl)amino)-1-isopropyl-cyclopentane-1-carboxamides as CCR2 antagonists.
Another promising oral agent for multiple sclerosis.
Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy.
Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis.
Orbital and optic nerve complications of inflammatory bowel disease.
Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.
Improving adherence to injectable disease-modifying drugs in multiple sclerosis.
Status migrainosus as an initial presentation of multiple sclerosis.
Prediction of disease severity in neuromyelitis optica by the levels of IL-6 produced during remission phase.
Prospect of brain-machine interface in motor disabilities: the future support for multiple sclerosis patient to improve quality of life.
Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies.
P wave duration and dispersion and QT interval in multiple sclerosis.
Neurosarcoidosis.
A Psychometric Validation of Two Brief Measures to Assess Palliative Need in Patients Severely Affected by Multiple Sclerosis.
Treatment of Neuromyelitis Optica Spectrum Disorder: Acute, Preventive, and Symptomatic.
Effects of Reducing Suppressors of Cytokine Signaling-3 (SOCS3) Expression on Dendritic Outgrowth and Demyelination after Spinal Cord Injury.
Examining Trait Mindfulness, Emotion Dysregulation, and Quality of Life in Multiple Sclerosis.
Medication use in a large international sample of people with multiple sclerosis: associations with quality of life, relapse rate and disability.
Redox-based regulation of neural stem cell function and Nrf2.
Cow's milk allergy in multiple sclerosis patients.

Pages